Statens Serum Institut

We strengthen health through disease control and research.

SSI has more than 100 years of experience in research, development and manufacturing of biologics.

COVID-19

20 January 2022

See our guide to English and Danish COVID-19-information

Read more

News

Now, an Omicron variant, BA.2, accounts for almost half of all Danish Omicron-cases

20 January 2022
The risk of becoming infected with the Delta variant and of transmitting the variant to other people is lower for vaccinated persons

17 January 2022
Discovery of genetic variants linked to febrile seizures

17 January 2022
Rapid antigen tests can detect new variants

12 January 2022
Omicron report is discontinued since cases of Omicron now account for more than 90 %

7 January 2022

More News

Temaer

Vaccine Research

Vaccine Research

Vaccine research at Statens Serum Institut goes back to the institute’s founding in 1902, when it was set up to produce antisera for Diphtheria. Research soon expanded to other epidemic diseases. Today the main effort is devoted to vaccines against tuberculosis, chlamydia, HIV and novel adjuvants to direct and potentiate the immune responses.

Childhood vaccination programme

Childhood vaccination programme

Vaccinations are given by the local general practitioners who also give advice to the parents. There is no fee for vaccinations given to persons under 18 years of age.

Danish National Biobank

Danish National Biobank

The Danish National Biobank stores millions of samples available for use in specific research projects.

Antibodies

SSI Antibodies develops, produces and sells monoclonal and polyclonal antibodies as well as growth media additives and MBL standards worldwide.